BNP Paribas Financial Markets’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $327K | Buy |
|
|||||
|
2025
Q2 | $42.4K | Sell |
|
|||||
|
2025
Q1 | $148K | Sell |
|
|||||
|
2024
Q4 | $346K | Buy |
|
|||||
|
2024
Q3 | $292K | Buy |
|
|||||
|
2024
Q2 | $27.4K | Sell |
|
|||||
|
2024
Q1 | $417K | Buy |
|
|||||
|
2023
Q4 | $251K | Buy |
|
|||||
|
2023
Q3 | $170K | Sell |
|
|||||
|
2023
Q2 | $514K | Sell |
|
|||||
|
2023
Q1 | $1.1M | Buy |
|
|||||
|
2022
Q4 | $528K | Sell |
|
|||||
|
2022
Q3 | $830K | Buy |
|
|||||
|
2022
Q2 | $223K | Sell |
|
|||||
|
2022
Q1 | $275K | Sell |
|
|||||
|
2021
Q4 | $565K | Sell |
|
|||||
|
2021
Q3 | $1.13M | Buy |
|
|||||
|
2021
Q2 | $625K | Sell |
|
|||||
|
2021
Q1 | $452K | Buy |
|
|||||
|
2020
Q4 | $384K | Buy |
|
|||||
|
2020
Q3 | $133K | Sell |
|
|||||
|
2020
Q2 | $674K | Buy |
|
|||||
|
2020
Q1 | $314K | Buy |
|
|||||
|
2019
Q4 | $194K | Buy |
|
|||||
|
2019
Q3 | $109K | Buy |
|
|||||
|
2019
Q2 | $80.8K | Sell |
|
|||||
|
2019
Q1 | $197K | Buy |
|
|||||
|
2018
Q4 | $444 | Sell |
|
|||||
|
2018
Q3 | $39.1K | Hold |
|
|||||
|
2018
Q2 | $32.4K | Sell |
|
|||||
|
2018
Q1 | $157K | Buy |
|
|||||
|
2017
Q4 | $141K | Buy |
|
|||||
|
2017
Q3 | $80.6K | Sell |
|
|||||
|
2017
Q2 | $78K | Buy |
|
|||||
|
2017
Q1 | $2.9K | Sell |
|
|||||
|
2016
Q4 | $32.7K | Sell |
|
|||||
|
2016
Q3 | $42.2K | Sell |
|
|||||
|
2016
Q2 | $487K | Buy |
|
|||||
|
2016
Q1 | $352K | Sell |
|
|||||
|
2015
Q4 | $872K | Buy |
|
|||||
|
2015
Q3 | $102K | Buy |
|
|||||
|
2015
Q2 | $44.1K | Buy |
|
|||||
|
2015
Q1 | $8.64K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $21.1K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $5.34K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $97.6K | Buy |
|